Phaseline

Targets › NOS

NOS: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Other; next expected readout Oct 2027.

Open in Phaseline: the race on NOS, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of Pennsylvania[18F]NOS
Nitric oxide synthase (NOS) radiotracer
NOSPhase 1Smoking, CigaretteOct 2027

Conditions

Smoking, Cigarette (1)

Modalities

small molecule (1)

Companies

University of Pennsylvania (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.